Taysha Gene Therapies, Inc.TSHANASDAQ
LOADING
|||
Net Income Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year net income growth rate
Latest
-21.77%
↑ 58% above average
Average (23q)
-52.20%
Historical baseline
Range
High:140.77%
Low:-387.09%
Volatility
-1011.3%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | -21.77% |
| Q2 2025 | -24.86% |
| Q1 2025 | -14.61% |
| Q4 2024 | 26.40% |
| Q3 2024 | -21.96% |
| Q2 2024 | 13.02% |
| Q1 2024 | -150.40% |
| Q4 2023 | 140.77% |
| Q3 2023 | -376.00% |
| Q2 2023 | -39.59% |
| Q1 2023 | 68.38% |
| Q4 2022 | -110.06% |
| Q3 2022 | 22.19% |
| Q2 2022 | 32.25% |
| Q1 2022 | 0.14% |
| Q4 2021 | 1.56% |
| Q3 2021 | -25.07% |
| Q2 2021 | -27.80% |
| Q1 2021 | -74.82% |
| Q4 2020 | -21.78% |
| Q3 2020 | 29.11% |
| Q2 2020 | -290.72% |
| Q1 2020 | -387.09% |
| Q4 2019 | 0.00% |